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ABSTRACT 
In the present era due to speeder change of the civilization, human habits and life style continuously changing without any consideration of their 
benefits or harms Adaptation of new diets, movement with fast moving vehicles, maintenance of wrong postures, avoidance or over-indulgence of 
exercise, suppression of natural urges, anxiety strain etc. of the present life are becoming responsible for increasing incidence of Vatavyadhi like 
Pakshaghat (Hemiplegia.) These diseases mostly treated by allopathic medicines(high dose of corticosteroids) which are having considerable side 
effects and could not be used on long term basis. So conclusion is that in these disease, the dose of allopathic medicines and disease gradually 
progresses and in addition due to the side effects of allopathic medicines, it is better that these diseases should be treated by Ayurvedic medicines. 
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INTRODUCTION 
Stroke1 is a world-wide health problem; with incidence ranging 
from 0.2 to 2.5 per thousand per year according to WHO 
Collaborative Study in 12 countries. It accounts for 20% of 
neurological admissions. Till date, in India there have been only a 
few community based studies for either prevalence or incidence of 
stroke; with one reporting a prevalence rate of 334/100,000 and an 
incidence of 73/100,000 in 19902. Post-stroke hemiplegia is one of 
the most common causes of disability in adults. Prevalence of 
hemiplegia in South India is 56.9 per 100,000; as compared to 150 to 
186 per 100,000 in the USA and Europe. Hemiplegic shoulder pain 
(HSP) is one of the commonest complications, occurring in about 20-
72% of such patients with average figures ranges from 43 to 64%3-
10. Kalichman and Ratmansky11 reported prevalence of HSP is 
approximately 22%-23% in the general population of stroke 
survivors and approximately 54%-55% among stroke patients in 
rehabilitation settings. In day- today practice Pakshaghat disease is 
common in Ayurvedic OPD& IPD. As compare to modern medical 
science after Emergency manegment on Pakshaghat, they prescribe 
physiotherapy, which is not so much beneficial. 
Losnua Lusgla;qDra i{kk?kkrs fojspue~ AA ¼p-fp- 28@100½ 
Generally the Vatavyadhi is managed by Snehan-Swedan, 
Vastikarma etc. But according to Charakachrya Virechankarrna is 
the specific treatment for Pakshaghat roga. In Ayurveda there are 
specific treatments for pakshaghata. There are two types of 
treatment. One is Sodhan therapy and second is Shaman therapy. 
Shodan means purification of the body by eliminating morbid 
Doshas and Dushyas from body through Panchkarma, and main 
principal of Shaman therapy is to normalize and maintain the 
equilibrium of all their Doshas. After the Shodhan therapy comete 
Shaman chikitsa is indicated for pacifying reminant Doshas. 
In the present stage of socio-economic life the trend of disease 
management is to find out more effective, easily available and 
quickly responding remedies, which do not have any ill effect on 
health and longevity of the patient. 
 
The modern scientific mind is not satisfied by only giving 
statements, no matter from what source they originate, unless and 
until collaborated by clinical and experimental proof. if this could be 
achieved, Ayurveda could be brought into mass of humanity in the 
world. 
Aim and objectives 
To evaluate the effect of Virechan karma in the management of 
Pakshaghat (Hemiplegia)  
To assess the clinical effectiveness of Pakshaghatari Guggulu yog and 
Virechan Karma on Pakshaghat i.e. Shodhan (virechan) Purvak 
Shamak Chikitsa.  
To compare the effectiveness of both i.e. Shodhan Purvak shaman 
and Shaman Chikitsa 
MATERIAL AND METHOD 
For the present study 30 patients will be selected irrespective of 
their age, sex, religion etc. from OPD and IPD of Govt. Dhanwantri 
Ayurvedia Hospital, Ujjain. These 30 patients subdivided into 3 
groups. 
Group A:Patient will treat with Virechan therapy and after that 
placebo will be given total 30 days are required. 
Group B: In this group after Virechan and Samsarjan krama the 
research drug will be given up to 30 days. 
Group C: In this group only research drug will be given total course 
will be 30 days. 
Detailing of clinical study has been projected under the following 
manner. 
Criteria of Diagnosis 
The main Criteria of diagnosis of the patient were based on cardinal 
as associated symptoms mentioned in classical texts and parameter 
of nervous system examination. 
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Criteria of Inclusion 
Fully conscious patients 
All the patients of Pakshaghat above the age of 20 year 
Criteria of Exclusion 
Unconscious patients. 
Lost bowel and bladder control. 
Complicated with heart diseases. 
Intra cranial infection meningitis etc. 
Trauma, cerebral tumor, cerebral abscess. 
Marked impaired mental function. 
Criteria of Assessment 
Scoring system was adopted for cardinal as associated sing and 
systems (Doshanubandhi lakshan). 
Signs &Symptoms   Score 
Loss of speech (Vaksanga) 
Normal    0 
Speak with difficulty   1 
Speak few words   2 
Utter voice   3 
Aphasia    4 
Finger movement 
Normal    0 
Able to bold object   1 
Unable to bold object  2 
Slight    3 
No    4 
Lifting of Arm at shoulder/Leg at Hip joint (Flexion Extension) 
Up to to 180   0 
Up to 135    1 
Up to 90     2 
Up to 45    3 
No     4 
Standing from sitting 
Normal    0 
Without support   1 
With support   2 
Unable              3                                                                                                            
 
Muscle tone (Rigidity) 
 
Normal        0 
Mild rigidity   1 
Moderate rigidity   2 
Seven rigidity   3 
Loss of Muscle power 
Normal      0 
Not against resistance    1 
Power detachable when gravity excluded   2 
Flicker      3 
Complete paralysis     4 
Loss of sensation (Achetana) 
Normal      0 
Mild sensory loss     1 
Moderate sensory loss    2 
Sever to total Sensory loss    3 
Walking time (cover given distance in time [10 meter]) 
Less than 1 min      0 
Between 1-1:30 min     1 
Between 1:30-2min     2 
More than 2min      3 
Can't Walk     4 
Hand grip power by sphygmomanometer 
Above 40 mm Hg   0 
30-40 mm Hg   1 
20-30 mmHg   2 
10-20 mm Hg   3 
0-10 mm Hg   4 
Foot pressure on weighing machine 
Above 40 kg   0 
30-40 kg    1 
20-30 kg    2 
10-30 kg    3 
0-10 kg     4 
Reflexes 
Normal     0 
Brisk    1 
Very Brisk   2 
Clonus              3 
Ruja (Pain) 
No pain    0 
Only after some extension  1 
Less frequently   2 
Very frequently   3 
Gourava 
Normal     0 
Mild Gaurav   1 
Moderate Gourav   2 
Sever Gourav   3 
Sotha 
No Sotha    0 
Mild Sotha   1 
Moderate Sotha   2 
Severe Sotha   3 
Associated signs symptoms 
No deviation of face   0 
Slightly present   1 
Moderately present   2 
Markedly present   3 
On the basis of various haematological and biochemical parameter 
Routine hematological investigation like Hb, TLC, DLC, ESR. Were 
done before and after the treatment bio-chemical investigation like 
FBS and serum cholesterol were also done. 
Plan of study: - Pakshaghat is a Kricchsadhya Vyadhi. The 
therapeuticmeasures should be able to assuage symptoms and 
provide maximum relief to the patients. Bearing this in mind 
patients of Pakshaghat  were chosen from O.P.D. & I.P.D. of Govt. 
Dhanwantri Ayurved hospital irrespective of age, sex, and religion & 
exclusion criterion were taken into account before choosing the 
patients for the clinical trial. The patient was examined thoroughly 
and progress of the malady noted precisely weekly. Three group 
were made underneath is the details. 
Three group were designed for the present study 
Group A: - Shodhan group incorporated patient that were given 
Shodhan therapy i.e. Virechan and after placebo were given.  
Group-B: - encompassed patient that were given Shodhan therapy 
than Shaman drug Pakshaghatari Guggulu is given. 
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Group A-Shodhan Grou 
10 patients were registered in this group All patients completed the course. In this category, snehan svedan than virechan karm was this is followed 
by dispensing of capsule of placebo Following is the schedule following in this group. 
 
*Dependa on Samyak Snigdha Lakhans. **Empty stomach in the morring 9:00 A.M. ***Depends on Shudhi Prakar Uttam, Hin Madhyam. ****Depends 
on Shudhi: Total Duration of course 30 days step 1-6 was followed in systemic order 
Method of prepration 
Method of prepration Murcchit til tail and Virechan has been 
described in Drug review section. 
Mode of Dispensing 
Glucose was dispended in the form of capsule of 125mg. 
Anupan:-Anupan of Virechan kalp & placebo is Leukwarm water. 
Aushadhkal 
Virechana kalp in preribed in morning hours after sunrise at 9:00 
A.M. placebo given after meals. 
Group B 
Shodhan therapy than Shaman drug group 10 patients were 
registered in this group all patient completed this course: In this 
category, Snehan svedan than Virechan karm was performed this 
was succeeded by Samsarjan karm which relied in the type of Shudhi 
achieved in Virechan. Thes is following in the schedule followed in 
this group. 
 
*Depends on Samyak snighdha lakshan. **After sunrise in the morning 9:00 A.M. ***Depends on shudhi prakar-Uttam, Hin Madhyam. ***Depends on 
shudhi total duration of course 30 days step 1to 6 was followed in systemic order. 
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Method of preparation 
Method of murcchit til tail and virechan kalp has been described in 
drug review section 
Method of Dispensing 
Pakshaghatari Guggulu was dispensed in the form of pouch 
according to dose. 
Anupan  
Anupan of virechan kalp and Pakshaghatari Guggulu is Leukwarm 
water. 
Anushadhkal  
Virechan kalp is deseribed in morning hours after sunrise at 9.00 
A.M.& pakshaghatri Guggulu is given after meals. 
Group C- Shaman Group 
10 patients were registered in the group and all patients completed 
this course Pakshaghari Guggulu was administered to 10 patients. 
Method of Preparation 
Method of preparation has been specified in drug review section. 
Mode of Dispensing 
1gm tablet given for 2 gm BID Dose for 30 days duration. 
Dose and Anupana : 2gm BID with lukewarm water  
Aushadhkal :After meals.. 
Statistical Analysis 
The result of the therapy was assessed after accomplishment of the 
treatment All the available data was statically analyzes by applying 
''period test '' The calculated value was compared with tabulated 
value and the Sequel assessed at various probabilities The results 
obtained were interpreted as :- 
Significant  - p < 0.01 
Highly Significant  - p<0.001 
Observation and results 
Table1: Total Effect Cardinal Sign & Symptoms of 10 patients of Hemplegia in Group A. 
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Table3: Total Effect Cardinal Sign & Symptoms of 10 patients of Hemplegia in Group C. 
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Figures1: Percentage of relief in cardinal sings & symptoms of Hemplegia in all three Groups 
 
Table 5: show t value and P value of the Symptoms after one month clinical trial (if P value<0.20 to >0.05=insignificant, if P value≤0.05 to 
>0.01=significant, if P value ≤0.01 to <0.001= highly significant) 
 
 
Table5: Total effect of therapy on laboratory parameters of 10 patients of Group A 
 
In Group A : 
Hb% was increased by 1.86% that was statistically insignificant (p 
>0.10) 
TLC was decreased in Group A 3.86% change was seen in readings, 
that wss statically insignificant. 
E.S.R. was increased in Group A 3.86% change was seen in readings, 
that was statically insignificant.  
S.Cholesterol. was decreased by 4.61% Group A that was also 
insignificant  
F.B.S. was found to be decreased by 1.39% in Group A that was also 
insignificant statistically. 
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Table6: Total Effect of therapy on laboratory parameters of 10 patients in Group B. 
 
In Group B :Hb% was increased by 4.88% in group B that was insignificant. TLC was increased by 5.92% in Group B that was insignificant. 
E.S.R. was decreased by 2.68% Group B that was insignificant. S.Cholesterol. was increased by 1.527% in Group B that was statistically 
insignificant. F.B.S. was decreased by 13.03% in Group B that was statistically insignificant. 
 
Table7:Total Effect on laboratory parameters of 10 patients in Group C. 
 
 
In Group C: Hb% was increased by 6.22% in Group C that was statically insignificant. TLC was decreased by 2.31% in Group C that was 




Table8: Total Effect of therapy of 30 patients of Hemiplegia 
 
Complete remission was found in 10% in Group B only. As a whole of 30 patients studied, complete remission was found in 3.33% in Group B As a 
whole of 30 patients studied complete cure was found in 3.33%. Marked improvement was obtained in 40% in Group A, 50% patients of Group B, 
30% patients of Group C. As a whole of 30 patients studied marked improvement was found in 40%. Moderate improvement was obtained in 60% 
in Group A, 40% patients of Group B 50% patients of Group C. As a whole of 30 patients studied moderate improvement was found in 50%. Mild 
improvement was found in 20% in Group C only. As whole of 30 pt. studied mild improvement was found 6.66%. No patient remained unchanged by 
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